BridgeMD
Tests treatment safety and results for Ulcerative Colitis (UC)
Official title Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
ClinicalTrials.gov ID: NCT06850727
What this study is testing
What is OD-07656?
OD-07656 is an investigational medicine, being studied as a potential treatment for ulcerative colitis (uc).
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this study is to evaluate the clinical efficacy and safety of OD-07656 in participants with moderately to severely active ulcerative colitis (UC). In addition, the study will evaluate the potential of OD-07656 to enhance the therapeutic benefit of vedolizumab when given after OD-07656.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- The main include but are not limited to the following:
- Has a confirmed diagnosis of ulcerative colitis (UC)
- Has moderate to severely active UC as defined by the 3-component Modified Mayo clinic score
- Has an inadequate response, loss of response, or intolerance/medical contraindication to at least one of the following therapies: oral...
You likely can't join if
- The main exclusion criteria include but are not limited to the following:
- Has diagnosis of Crohn's disease or indeterminate colitis
- Has had extensive colonic resection
- Has colostomy or ileostomy
- Has uncontrolled primary sclerosing cholangitis
The study team makes the final eligibility decision.
Where it's taking place
- Birtinya, Australia
- Box Hill, Australia
- Maroochydore, Australia
- Melbourne, Australia
- Murdoch, Australia
- Parkville, Australia
- Graz, Austria
- Montreal, Canada
- Polička, Czechia
- Amman, Jordan
- Irbid, Jordan
- Kaunas, Lithuania
- Chisinau, Moldova
- Auckland, New Zealand
- Christchurch, New Zealand
- Hamilton, New Zealand
- Nelson, New Zealand
- Upper Hutt, New Zealand
- Bydgoszcz, Poland
- Chojnice, Poland
+ 9 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Birtinya, Australia; Box Hill, Australia; Maroochydore, Australia; Melbourne, Australia; Murdoch, Australia; Parkville, Australia and 23 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.